$684 Million is the total value of Iron Triangle Partners LP's 23 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 52.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $63,091,314 | -14.9% | 501,800 | +6.8% | 9.22% | -7.0% |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $53,801,493 | +34.2% | 765,204 | +52.0% | 7.86% | +46.7% |
| DXCM | Buy | DEXCOM INC | $52,784,755 | +173.8% | 565,753 | +277.2% | 7.71% | +199.3% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $47,576,127 | +7.8% | 210,635 | +5.3% | 6.95% | +17.8% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $41,505,180 | +1.2% | 142,000 | +18.3% | 6.07% | +10.6% |
| ELAN | New | ELANCO ANIMAL HEALTH INC | $38,354,814 | – | 3,412,350 | +100.0% | 5.60% | – |
| ABBV | Sell | ABBVIE INC | $37,265,000 | -38.5% | 250,000 | -44.4% | 5.45% | -32.8% |
| APLS | New | APELLIS PHARMACEUTICALS INC | $33,475,200 | – | 880,000 | +100.0% | 4.89% | – |
| GKOS | Buy | GLAUKOS CORP | $32,357,500 | +46.6% | 430,000 | +38.7% | 4.73% | +60.3% |
| ICLR | Sell | ICON PLC | $32,012,500 | -63.4% | 130,000 | -62.9% | 4.68% | -60.0% |
| MCK | New | MCKESSON CORP | $30,439,500 | – | 70,000 | +100.0% | 4.45% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $30,403,090 | – | 452,629 | +100.0% | 4.44% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $27,976,083 | -24.2% | 570,126 | +6.0% | 4.09% | -17.1% |
| TXG | Buy | 10X GENOMICS INC | $27,511,481 | +29.7% | 666,945 | +75.5% | 4.02% | +41.8% |
| BRKR | New | BRUKER CORP | $26,841,519 | – | 430,843 | +100.0% | 3.92% | – |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $21,120,000 | -54.1% | 400,000 | -52.9% | 3.09% | -49.8% |
| BKD | Buy | BROOKDALE SR LIVING INC | $17,537,570 | -0.7% | 4,236,128 | +1.3% | 2.56% | +8.6% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $17,218,297 | – | 330,549 | +100.0% | 2.52% | – |
| EXAS | Sell | EXACT SCIENCES CORP | $17,055,000 | -63.7% | 250,000 | -50.0% | 2.49% | -60.3% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $15,030,000 | -52.9% | 1,800,000 | -25.0% | 2.20% | -48.5% |
| OLK | Buy | OLINK HLDG ABsponsored ads | $10,886,415 | +84.4% | 738,062 | +134.5% | 1.59% | +101.6% |
| MASS | Buy | 908 DEVICES INC | $6,529,884 | +5.8% | 980,463 | +8.9% | 0.95% | +15.6% |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $3,472,878 | -71.5% | 150,211 | -67.7% | 0.51% | -68.8% |
| TMDX | Exit | TRANSMEDICS GROUP INC | $0 | – | -180,000 | -100.0% | -2.02% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCput | $0 | – | -196,000 | -100.0% | -2.47% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -70,000 | -100.0% | -3.04% | – |
| ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -65,000 | -100.0% | -3.07% | – |
| SGRY | Exit | SURGERY PARTNERS INC | $0 | – | -580,973 | -100.0% | -3.49% | – |
| COO | Exit | COOPER COS INC | $0 | – | -75,000 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.